Clinical Trial Update: Neurological Outcome After Erythropoietin Treatment for Neonatal Encephalopathy [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of Phase 1/2 studies evaluating erythropoietin for improving neurological outcomes in neonatal hypoxic-ischemi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxic-ischemic Encephalopathy

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Zhengzhou University | Conditions: Hypoxic-Ischemic Encephalopathy | Phase 1, Phase 2 | Status: COMPLETED